- RESEARCH BRIEFINGS
A study of more than one million people shows that rare genetic variants that disrupt the FNIP1 gene are associated with a favourable metabolic profile and a roughly 60% lower risk of cardiometabolic disease than the general population. Silencing genes in the FNIP1 pathway in mice induces fat breakdown and reproduces the metabolic benefits associated with the variants in humans.
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
£17.99 / 30 days
cancel any time
Subscribe to this journal
Receive 52 print issues and online access
£199.00 per year
only £3.83 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-02391-x
‘Expert opinion’ is published under a CC BY 4.0 licence and Figure 1 is published under a CC BY-NC-ND 4.0 licence.
References
-
Naghavi, M. et al. Lancet 403, 2100–2132 (2024).
-
Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr & Hobbs, H. H. N. Engl. J. Med. 354, 1264–1272 (2006).
-
Malik, N. et al. Science 380, eabj5559 (2023).
-
Saettini, F. et al. Blood 137, 493–499 (2021).
-
Sattler, E. C. & Steinlein, O. K. in GeneReviews (eds Adam, M. P. et al.) (Univ. Washington, 2024).
